Head-to-head for moms
CoreAge Rx vs Eve
CoreAge Rx and Eve both offer GLP-1 telehealth to mothers, but they make different trade-offs on family-budget value, clinical oversight, price and access. Here they are side-by-side on the Editors' Rating — our six-factor rubric for mothers.
CoreAge Rx
Higher scoreRanked #1 · Grade A
Best for: Mothers who want to know the real monthly cost before the free trial talks them into it — one flat price on semaglutide or tirzepatide, everywhere in the country, with no lock-in.
Visit CoreAge RxEve
Ranked #31 · Grade C
Best for: Mothers who want one flat price across both molecules and a genuine oral option, from a program explicitly positioned around women's health, and don't mind full pricing sitting behind the signup flow rather than the homepage.
Visit EveThe verdict
CoreAge Rx edges out Eve on the Editors' Rating, 94 to 70 (A vs C). Mothers who want to know the real monthly cost before the free trial talks them into it — one flat price on semaglutide or tirzepatide, everywhere in the country, with no lock-in.
Eve is still a genuine option — a flat $195 a month for either compounded semaglutide or tirzepatide — plus a sublingual oral version at the same price — from a program built specifically around women's health, though the states you're eligible in and the pharmacy behind it aren't spelled out until you're inside the signup flow. Weigh the six factors below against your own priorities.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | CoreAge Rx | Eve |
|---|---|---|
| Editors' Rating | 94/100 · A | 70/100 · C |
| Overall rank | #1 | #31 |
| Semaglutide | $99/mo | $195/mo |
| Tirzepatide | $149/mo | $195/mo |
| Coverage | All 50 states | Multiple states (not fully enumerated — confirm yours before signing up) |
| Brand-name access | Compounded only | Yes |
| Oral / sublingual | Injection only | Yes |
CoreAge Rx
Ranked #1 · Grade A
What we like
- Flat all-in price that doesn't step up after month one — the number you sign for is the number at the full dose
- Both compounded semaglutide and tirzepatide on a single account, so a molecule switch never resets the budget
- Licensed in all 50 states — care survives a move, a deployment, or a summer at the grandparents'
The caveats
- Not the rock-bottom sticker price — a bare teaser tier elsewhere can look cheaper for exactly one month
- Compounded only; no FDA-approved brand Wegovy or Zepbound if that is what you and your clinician want
- A general metabolic program, not a dedicated women's or maternal-health clinic
Eve
Ranked #31 · Grade C
What we like
- One flat $195/mo price covers either compounded semaglutide or tirzepatide, plus a sublingual oral option at the same rate
- Brand-name Ozempic, Wegovy and Mounjaro are also available on the same platform for a reader who wants an FDA-approved pen
- "You pay $0 unless approved by a licensed physician" — no charge for a declined intake, per its own copy
The caveats
- Full standing pricing sits behind the go.tryeve.co signup flow — the public site only shows the $0/$99 promo fragment up front, not the $195 ongoing rate
- States aren't enumerated; the site only promises it will follow you if you move to a state it currently serves
- Pharmacy partner name, 503A/503B designation, medical director and corporate entity are not disclosed
We may earn a referral fee if you sign up through a link on this page, at no extra cost to you — and it has no bearing on which provider scores higher. Pricing, states and verification reflect each provider's public disclosures at last review; the Editors' Rating is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Keep comparing CoreAge Rx and Eve against other providers we review for mothers.
Or browse the full comparison hub.